𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P-21 A phase II trial of weekly paclitaxel in advanced non-small cell lung cancer non-suitable for platinum-based chemotherapy. Spanish lung cancer group/GECP 00-02

✍ Scribed by Massutí, Bartomeu; Camps, Carlos; Garrido, Pilar; Barceló, JoséRamón; Vin˜olas, Núria; Barneto, Isidoro; Bover, Isabel; Chaib, Carlos; Martí-Ciriquián, Juan Luis; Rosell, Rafael


Book ID
118571722
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
193 KB
Volume
41
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Platinum-based combination chemotherapy
✍ Green, Mark R. ;Kramar, Andrew ;Schilsky, Richard ;Stoopler, Marc ;Zimmer, Bonni 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Cancer and Leukemia Group B (CALGB) utilized a randomized phase II trial design to evaluate two cisplatin‐based combinations, cisplatin‐cytarabine (ara‐C) and cisplatin‐vinblastine, in 151 patients with advanced non‐small cell lung cancer. Patients entered on study had not received